DUPILUMAB

From Port-Wine Stain Treatments to Bovine Colostrum, Telomeres, and Skin Aging
Port-Wine Stain
by NEXT STEPS IN DERM TEAM on
The May issue of the Journal of Drugs in Dermatology features dermatology articles on topics ranging from treatment updates on Port-Wine stain to the protective effect that liposomal bovine colostrum exerts on skin aging using telomere length as an aging biomarker. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Authors analyze extrusion forces of various produ …
Recalcitrant Dyshidrotic Eczema Treated With Dupilumab
eczema
by NEXT STEPS IN DERM TEAM on
The following two cases presented by JDD authors Ryan A. Gall MD, John D. Peters MD, and Alyson J. Brinker MD add to the growing literature supporting the use of dupilumab in the treatment of patients with recalcitrant dyshidrotic eczema, both with and without diagnosed contact allergens. Introduction Dyshidrotic eczema, also known as dyshidrosis or pompholyx when involving larger bullae, is a c …
Novel Therapeutics in Atopic Dermatitis
Novel Therapies Atopic Dermatitis
by Mojgan Hosseinipour, DO, FAAD on
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories: Immune dysregulation Abnormal skin barrier Abnormal itch/scratch cycle Abnormal skin microbiome In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi …
Dupilumab Therapeutic Cheat Sheet
Dupilumab
by Azam Qureshi, MD on
Atopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …
Beyond the Basics: Systemic Treatment for Atopic Dermatitis and Evaluation of Infantile Hemangiomas
Infantile Hemangiomas
by Edita Newton, MD on
To kick off ODAC 2021, Dr. Yasmine Kirkorian, MD, tackled two clinical dilemmas that are frequently seen among pediatric patients in the dermatology office: poorly controlled atopic dermatitis and infantile hemangiomas. Dr. Kirkorian reviewed currently available systemic therapies for atopic dermatitis as well those in the drug development pipeline. She went into detail about how she utilizes he …